You are here
- Home
- Therapy Areas
- Neuroscience
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients with Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
- Disease
- pain
- Drug Name
- NKTR 118
- Generic Name
- NKTR-118
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- III
- Start Date
- Mar 28, 2011
- Study Name
- D3820C00005
- Study Id
- D3820C00005
- ClinicalTrials.gov ID
- NCT01323790
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
